首页 › 基金 › New Vernon Capital Holdings II LLC › HRMY
New Vernon Capital Holdings II LLC 对 HRMY 的持仓历史
HARMONY BIOSCIENCES HLDGS IN · 医疗保健
New Vernon Capital Holdings II LLC 在 Q3 2026 的 13F 申报中披露持有 HRMY(HARMONY BIOSCIENCES HLDGS IN)6,983 股,市值约 US$274K,约占其申报组合的 0.17%,在其申报持仓中市值排名第 33 位。 New Vernon Capital Holdings II LLC 最近 12 个申报季度中有 12 个季度披露了 HRMY 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
New Vernon Capital Holdings II LLC 对 HRMY 的持仓演变
New Vernon Capital Holdings II LLC 于 Q4 2023 首次披露 HRMY 持仓:14,036 股(约 US$453K)。 该持仓在 Q1 2025 达到峰值 488,424 股,市值约 US$14.7M。 在 12 次申报中,New Vernon Capital Holdings II LLC 3 次增持、2 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 6,983 股、市值约 US$274K,环比增持 2,442 股。。 持仓曾出现大幅变动:Q1 2025 增持约 3219% (随后一个季度股价下跌 5%)、Q2 2025 减持约 97% (随后一个季度股价下跌 13%)、Q3 2025 减持约 69% (随后一个季度股价上涨 36%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 14.04K | $453.36K | 新进 |
| Q1 2024 | 14.72K | $494.16K | 增持 |
| Q2 2024 | 14.72K | $443.98K | 持有 |
| Q3 2024 | 14.72K | $588.64K | 持有 |
| Q4 2024 | 14.72K | $506.38K | 持有 |
| Q1 2025 | 488.42K | $14.72M | 增持 |
| Q2 2025 | 14.72K | $465.03K | 减持 |
| Q3 2025 | 4.54K | $125.15K | 减持 |
| Q4 2025 | 4.54K | $169.92K | 持有 |
| Q1 2026 | 4.54K | $127.19K | 持有 |
| Q2 2026 | 4.54K | $165.34K | 持有 |
| Q3 2026 | 6.98K | $274.15K | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HRMY 与 13F 数据
HRMY(HARMONY BIOSCIENCES HLDGS IN)属于医疗保健行业。我们追踪的基金中还有 38 只申报持有 HRMY,申报仓位最大的包括:ARMISTICE CAPITAL, LLC (US$56.4M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HRMY 的基金
- ARMISTICE CAPITAL, LLC 1.44M 股 · $56.38M · Q3 2026
- Valor Management LLC 818.01K 股 · $29.78M · Q2 2026
- venBio Partners LLC 472.19K 股 · $17.19M · Q2 2026
更多关于 New Vernon Capital Holdings II LLC
常见问题
How long has New Vernon Capital Holdings II LLC held HRMY?
New Vernon Capital Holdings II LLC has disclosed HRMY holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is New Vernon Capital Holdings II LLC's current position in HRMY?
As of Q3 2026, New Vernon Capital Holdings II LLC holds 6.98K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $274.15K, representing 0.17% of its reported portfolio and ranking #33.
Has New Vernon Capital Holdings II LLC been buying or selling HRMY?
In the latest 13F filing (Q3 2026), New Vernon Capital Holdings II LLC increased its position in HRMY. The position peaked in Q1 2025 at 488.42K shares.
Which other funds hold HRMY?
Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.